Weighted Average Number of Shares Outstanding, Basic of Design Therapeutics, Inc. from Q2 2021 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Design Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2025.
  • Design Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 57M shares, a 0.58% increase year-over-year.
  • Design Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 56.6M shares, a 1.08% increase from 2023.
  • Design Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 56M shares, a 0.5% increase from 2022.
  • Design Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 55.7M shares, a 21.3% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)

Design Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 57M +330K +0.58% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q2 2025 56.9M +303K +0.54% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 56.8M +269K +0.48% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q4 2024 56.6M +602K +1.08% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-10
Q3 2024 56.6M +632K +1.13% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q2 2024 56.6M +607K +1.09% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 56.5M +580K +1.04% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q4 2023 56M +277K +0.5% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-10
Q3 2023 56M +206K +0.37% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 55.9M +278K +0.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 55.9M +401K +0.72% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 55.7M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 55.8M +627K +1.14% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 55.7M +589K +1.07% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 55.5M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 55.2M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 55.1M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08

Design Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 56.6M +602K +1.08% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-10
2023 56M +277K +0.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-10
2022 55.7M +9.77M +21.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 45.9M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.